TrialJournal of clinical pharmacology2014

Effectiveness of clopidogrel dose escalation to normalize active metabolite exposure and antiplatelet effects in CYP2C19 poor metabolizers.

Richard B Horenstein et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.